Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP634485.RAr5AzJ_mIbV4X9Gmi00nI1lUj-uGM3pt2zdYUD8GaHdc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP634485.RAr5AzJ_mIbV4X9Gmi00nI1lUj-uGM3pt2zdYUD8GaHdc130_assertion type Assertion NP634485.RAr5AzJ_mIbV4X9Gmi00nI1lUj-uGM3pt2zdYUD8GaHdc130_head.
- NP634485.RAr5AzJ_mIbV4X9Gmi00nI1lUj-uGM3pt2zdYUD8GaHdc130_assertion description "[These findings indicate that the CysLTR1 promoter polymorphism is a useful genetic marker for predicting LTRA requirements in the long-term management of AIA patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP634485.RAr5AzJ_mIbV4X9Gmi00nI1lUj-uGM3pt2zdYUD8GaHdc130_provenance.
- NP634485.RAr5AzJ_mIbV4X9Gmi00nI1lUj-uGM3pt2zdYUD8GaHdc130_assertion evidence source_evidence_literature NP634485.RAr5AzJ_mIbV4X9Gmi00nI1lUj-uGM3pt2zdYUD8GaHdc130_provenance.
- NP634485.RAr5AzJ_mIbV4X9Gmi00nI1lUj-uGM3pt2zdYUD8GaHdc130_assertion SIO_000772 17924829 NP634485.RAr5AzJ_mIbV4X9Gmi00nI1lUj-uGM3pt2zdYUD8GaHdc130_provenance.
- NP634485.RAr5AzJ_mIbV4X9Gmi00nI1lUj-uGM3pt2zdYUD8GaHdc130_assertion wasDerivedFrom befree-2016 NP634485.RAr5AzJ_mIbV4X9Gmi00nI1lUj-uGM3pt2zdYUD8GaHdc130_provenance.
- NP634485.RAr5AzJ_mIbV4X9Gmi00nI1lUj-uGM3pt2zdYUD8GaHdc130_assertion wasGeneratedBy ECO_0000203 NP634485.RAr5AzJ_mIbV4X9Gmi00nI1lUj-uGM3pt2zdYUD8GaHdc130_provenance.